Navigation Links
Cardiogenesis Announces Addition of Raymond W. Cohen to Board of Directors
Date:12/2/2008

IRVINE, Calif., Dec. 2 /PRNewswire-FirstCall/ -- Cardiogenesis Corporation (Pink Sheets: CGCP), a leading developer of surgical products used in the treatment of patients suffering from severe angina, today announced the addition of veteran medical device executive and an experienced public company director, Raymond W. Cohen as a member of the Company's Board of Directors, increasing the number of board members to six.

Mr. Cohen, 49, has over 25 years of executive experience in the medical technology field and is currently the Chief Executive Officer and a member of the Board of Directors of Symphony Medical Inc., a venture-capital backed developer of novel biotherapeutic therapies to treat heart failure and other cardiac abnormalities.

For the decade prior to 2006, Cohen served as Chairman and CEO of publicly traded Cardiac Science, Inc. having served in that role during the period of rapid revenue growth and through the company's merger with Quinton Cardiology in late 2005. Today Cardiac Science is a leading manufacturer of automated public-access defibrillators and diagnostic cardiology systems, generating over $200 million in annual revenue. Cohen continues to serve on the board of Cardiac Science and also serves on the boards of BioLife Solutions, Inc., a publicly traded company, and BioGenex, Inc., and Syncroness, Inc.

Paul J. McCormick, the Company's Chairman of the Board commented, "Mr. Cohen has a solid track record of success in developing and commercializing innovative medical technology, particularly in the cardiovascular market. He brings the vision, insight and skills necessary to make a significant contribution to the Cardiogenesis Board of Directors and our shareholders. We are very pleased to have Mr. Cohen join our board and look forward to working with him."

About Cardiogenesis Corporation

Cardiogenesis specializes in provi
'/>"/>

SOURCE Cardiogenesis Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Cardiogenesis Reports Third Quarter 2008 Results
2. Cardiogenesis Reports Fourth Quarter and Full Year 2007 Results
3. Cardiogenesis Corporation to Report Third Quarter 2007 Results on November 14th
4. Encorium Announces Receipt of Letter from Nasdaq Regarding its Third Quarter 2008 Form 10-Q Filing
5. Kiadis Pharma Announces Continued Collaboration With Professor Velardi on its Lead Product ATIR(TM)
6. Therapure Biopharma Inc. Announces Manufacturing Agreement with Biomedical Frontiers Incorporated -- Contract will Support Phase II Trials for Thalassemia Treatment
7. Rosetta Genomics Announces Conference Call and Webcast of Third Quarter Financial Results
8. Ceregene Announces Clinical Data From Phase 2 Clinical Trial of CERE-120 for Parkinsons Disease
9. Sosei Announces the Out-licensing of RS(+) Mefloquine to Treague Ltd for the Treatment and Prophylaxis of Malaria
10. Genoptix Announces Participation at the Twentieth Annual Piper Jaffray Healthcare Conference
11. Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...ION -- Gone hybrid . . . , Fuel economy rating...posted at the www.fueleconomy.gov web site, whic...tains for the U.S. Department of Energy and the U....p 10 vehicles on the best fuel economy list are hy...ty; 48 highway). "This list proves that hybrids ha...
(Date:11/5/2009)... Nov. 5 Imagenetix, Inc....William Spencer, President and CEO of Imagenetix, ...annual LD MICRO Conference on Thursday, December 3...les. ,, About LD MICRO ,, LD MICRO is a by-i...ding undervalued companies in the micro-cap space....
(Date:11/5/2009)...N.Y., Nov. 5 BioSpecific...ceutical company developing first-in-class collage... results for the third quarter ended September 30,...ptember of this year, the FDA,s Arthritis Advisory...2-0, the approval of XIAFLEX(TM) for the treatment...
(Date:11/5/2009)...alif., Nov. 5 WaferGen B...ing developer of state-of-the-art genetic analysis...Ph.D. has joined the company,s Scientific Advisory...and commercializing novel molecular diagnostics fo...the development of computational biology systems f...
Breaking Biology Technology:November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4
... This release is available in French . , An N...laid the groundwork for a lithium battery that can... of conventional lithium ion batteries. , The re...dent David Xiulei Ji and postdoctoral fellow Kyu T...electrochemical performance for a lithium-sulphur ...
... SEATTLE, May 18 /PRNewswire-FirstCall/ - Oncothyr...ced the presentation of data demonstrating the eff...l model of pulmonary fibrosis. The data were prese...ociate Professor, Pulmonary Medicine, Children,s H...merican Thoracic Society International Conference ...
... Non-Profit Biotech Calls on the Entire ALS Commun...ay Events , , CAMBRIDGE, Mass., May 18 The ALS ...its BBQ For ALS Awareness , is a national initiat...anding of ALS (amyotrophic lateral sclerosis), oth...h its goal, the campaign brings together three und...
Other Biology Technology:Canadian research team reports major breakthrough in lithium battery technology 2Oncothyreon's PX-866 is effective in preclinical model of pulmonary fibrosis 2Oncothyreon's PX-866 is effective in preclinical model of pulmonary fibrosis 3Campaign to Increase the Awareness and Understanding of Lou Gehrig's Disease Reaches 22 U.S. States 2Campaign to Increase the Awareness and Understanding of Lou Gehrig's Disease Reaches 22 U.S. States 3
(Date:11/4/2009)... DigitalPersona, Inc., a leader in ... today announced that WAND Corporation, a leading ...-service restaurants, has integrated DigitalPerson...S solutions. WAND,s quick-service customers can no...untability and deter unauthorized manager override...
(Date:11/4/2009)...re/ -- What,s the cost of saving a teenage life? W...ing from prescription medication abuse, there,s no... may be unaware that the lock-boxes they,ve instal...g timebomb of prescription drugs. That,s why MEDNE...l supplies, has formed an exclusive partnership wi...
(Date:11/4/2009)...e-FirstCall/ -- BIO-key International, Inc. (OTC B...metric identification software is showcasing donor...onference being held at the New Orleans Convention...ide hands-on product demonstrations of its state-o... Also, at 5 PM on Monday, October 26, Peter Lux, m...
Breaking Biology News(10 mins):WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 2WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 3MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3BIO-key(R) International Exhibiting at AABB TXPO 2Ohio Law Firm Warns of Birth Control Pill YAZ Yasmin Side Effects Lawsuits 54279 1Ohio Law Firm Warns of Birth Control Pill YAZ Yasmin Side Effects Lawsuits 54279 2Ohio Law Firm Warns of Birth Control Pill YAZ Yasmin Side Effects Lawsuits 54279 3Ohio Law Firm Warns of Birth Control Pill YAZ Yasmin Side Effects Lawsuits 54279 4Mysterious charge transport in self assembled monolayer transistors unraveled 13515 1Mysterious charge transport in self assembled monolayer transistors unraveled 13515 2Emdeon Inc Prices Initial Public Offering of Class A Common Stock at 2415 50 Per Share 54275 1Emdeon Inc Prices Initial Public Offering of Class A Common Stock at 2415 50 Per Share 54275 2Emdeon Inc Prices Initial Public Offering of Class A Common Stock at 2415 50 Per Share 54275 3Emdeon Inc Prices Initial Public Offering of Class A Common Stock at 2415 50 Per Share 54275 4
...ncestral line of parasitic bacteria, scientists ca...o revealed where you lived or who you spent time w...ow to look. , Stanford researchers with collabora...dation for opening such a window to the past using...ue uses genomic data to examine metabolic networks...
...cal model could be used to predict an individual,s...hildren,s Hospital Informatics Program (CHIP). Usi... the researchers showed that their predictive mode...ardioembolic stroke -- the most common form of str...reported in the March issue of Stroke . , "For c...
... warning signs of climate change in the upper atmo...e 2009 Tyler Prize for Environmental Achievement. ... and gold medals, will go to Richard Alley, profes...eerabhadran (Ram) Ramanathan, professor of atmosph...on of Oceanography at the University of California...
Other Biology News:Reversing ecology reveals ancient environments 2Predicting risk of stroke from one's genetic blueprint 2Winners of Tyler environmental prize announced 2
...Linear Ion Trap Time of Flight Mass Analyzer for s...power., Specifications:, * MS mode measurement r...range: 150 - 4000 m/z, * Resolution: 14,000 (1400 ...eference, * Dynamic range: 4 orders of magnitude ...
...lay Vector is specifically designed to target and ...charomyces cerevisiae. Displayed proteins can be a...r putative ligands. pYD1 uses the a-agglutinin yea..., Aga1 and Aga2, to display recombinant protein on...
...is a pleiotropic cytokine produced by activated T ...nhibits the growth of some tumour and normal cell ...osis sarcoma cell proliferation, cytokine release ... receptor expression on hepatoma cells. Mouse OSM ...
Mouse Anti-Human BTAF1 Polyclonal Antibody, Unconjugated from Novus Biologicals
Biology Products: